New Icon collab looks to meet demand for real world evidence

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/metamorworks)
(Image: Getty/metamorworks)

Related tags: EHR, Electronic health record, Icon, Real world evidence, RWE

Icon and Practice Fusion have teamed up to meet the expanding demand for real world evidence – and aim to transform the way research is conducted.

Practice Fusion – an Allscripts company – is a cloud-based ambulatory electronic health record (EHR) platform, which supports more than 20,000 US-based medical practices providing care for more than 5m patients monthly.

“Our biopharmaceutical customers are demanding end to end, innovative solutions involving multiple partners who can be effectively aligned to meet evolving real world research needs,”​ said Jim Carroll, vice president, real world evidence, commercialization and outcomes, Icon.

The Icon and Practice Fusion collaboration aims to deliver on this objective, he told us.

Carroll said the companies are “taking a novel approach to combine assets in a way that can satisfy the expanding demand for real world evidence across key life science stakeholders.”

“Overall, we see our collaboration as a disruptive platform that can transform how research is conducted,”​ he added.

Several studies are ongoing and the companies continue to pursue additional ways of providing value to biopharmaceutical and medical device companies, Carrol explained.

“The collaboration is evergreen and will continue as long as we are collectively delivering innovative solutions to customers,”​ he added. “We are just getting started.”

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more